Search results
R79.89 is a billable diagnosis code used to specify a medical diagnosis of other specified abnormal findings of blood chemistry. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2024 through September 30, 2025.
5 lut 2019 · Know the lingo, sequencing, and progression to capture the correct condition codes. Diagnostic coding for neoplasms — especially malignant neoplasms — affects not only provider payment, but (more significantly) patient outcomes and healthcare priorities.
R79.89 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2025 edition of ICD-10-CM R79.89 became effective on October 1, 2024. This is the American ICD-10-CM version of R79.89 - other international versions of ICD-10 R79.89 may differ.
Other abnormal findings of blood chemistry R79-. Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions the ICD-10-CM has a coding convention that requires the underlying condition be sequenced first followed by the manifestation.
There are often multiple ICD-10 codes for a given ICD-9 code, so use caution! Contents. 1Oncology, solid tumor cancer diagnoses. 1.1Metastases to locations. 2Oncology, hematologic diagnoses. 2.1Leukemia & multiple myeloma. 2.2Lymphoma. 2.2.1Anatomic modifiers. 2.3Myeloproliferative neoplasms. 2.4Bone marrow transplant. 3Hematology, benign.
Ammonia is a waste product that bacteria in your intestines make when digesting protein. Ammonia is toxic and ammonia levels in your blood are normally very low.
Hyperammonemia is a condition that happens when you have high levels of ammonia in your blood. It can be life-threatening and requires immediate medical treatment. Hyperammonemia has several causes. The two most common causes are liver disease and urea cycle disorders. Digestive Care.
